Clinical Trial Update: Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety study of XL147 (SAR245408) in combination with paclitaxel and carboplatin in adults with solid tumors has been completed, involving cancers inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• XL147 (SAR245408)

Snippet

Sponsor: Sanofi | Conditions: Cancer, Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED